U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One):
[X] Form 10-K [ ] Form 20-F [ ] 11-K [ ] Form 10-Q [ ] Form N-SAR
For Period Ended: April 30, 1996
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:
_________________________________________________________________
_________________________________________________________________
Nothing in this form shall be construed to imply that the
Commission has verified any information contained herein.
_________________________________________________________________
If the notification relates to a portion of the filing
checked above, identify the Item(s) to which the notification
relates: ________________________________________________________
_________________________________________________________________
Part I - Registrant Information
_________________________________________________________________
Full Name of Registrant: Biosynergy, Inc.
Former Name if Applicable: Not Applicable
Address of Principal Executive Office (Street and Number):
1940 E. Devon Avenue, Elk Grove Village, Illinois 60007
_________________________________________________________________
Part II - Rules 12b-25 (b) and (c)
_________________________________________________________________
If the subject report could not be filed without
unreasonable effort or expense and the registrant seeks relief
pursuant to Rule 12b-25(b), the following should be completed.
(Check if appropriate) Yes ________ No _________
(a) The reasons described in reasonable detail in Part
III of this form could not be eliminated without unreasonable
effort or expense;
<PAGE>
(b) The subject annual report, semi-annual, transition
report on Form 10-K; Form 20-F, 11-K or Form N-SAR, or portion
thereof will be filed on or before the fifteenth calendar day
following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q, or portion thereof
will be file don or before the fifth calendar day following
the prescribed due date; and
(c) The accountant's statement or other exhibit required by
Rule 12b-25(c) has been attached if applicable.
_________________________________________________________________
Federal Securities Laws Section 33,321
Part III - Narrative
_________________________________________________________________
State below in reasonable detail the reasons why Form 10-K,
20-F, 11-K, 10-Q, N-SAR or the transition report or portion
thereof could not be filed within the prescribed time period.
The Registrant is required to file its annual report on Form
10K on or before July 29, 1997. The annual report has been
drafted and all financial statements completed. The attorneys
for the Registrant recently converted to a Windows 95 computer
operating system. For unknown reasons, the conversion of the
annual report to EDGAR is not operating properly and the annual
report must be redrafted on the old computer system. As a result
of these unforeseen problems, the Registrant is unable to file
its annual report and thus needs additional time.
<PAGE>
Part IV - Other Information
_________________________________________________________________
(1) Name and telephone number of person to contract in
regard to this notification: Lauane C. Addis (312) 236-4111
(2) Have all other periodic reports required under section
13 or 15(d) of the Securities Exchange Act of 1934 or section 30
of the Investment Company Act of 1940 during the preceding 12
months or for such shorter period that the registrant was
required to file such report(s) been filed? If the answer is
no, identify report(s). [X] Yes [ ] No
(3) Is it anticipated that any significant change in
results of operations from the corresponding period for the last
fiscal year will be reflected by the earnings statements to be
included in the subject report or portion thereof?
[ ] Yes [X] No
If so: attach an explanation of the anticipated change,
both narratively and quantitatively, and, if appropriate, state
the reasons why a reasonable estimate of the results cannot be
made.
Biosynergy, Inc.
_________________________________________________________________
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by
the undersigned thereunto duly authorized.
Date: July 28, 1997 By: /s/ LAUANE C. ADDIS /s/
____________________________
Lauane C. Addis, Secretary
INSTRUCTION: The form may be signed by an executive
officer of the registrant or by any other duly authorized
representative. The name and title of the person signing the
form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an
authorized representative (other than an executive officer),
evidence of the representative's authority to sign on behalf
of the registrant shall be filed with the form.
_________________________________________________________________
ATTENTION
Intentional misstatements or omissions of fact
constitute Federal Criminal Violations (See 18 U.S.C. 1001).
